'2016 is a landmark year for patients across Europe. The implementation of the Falsified Medicines Directive starts the journey towards safer medicines for all who need them. This process begins with the publication of the Delegated Regulation and ends will all member states protecting their citizens with a secure, fast and reliable medicine authentication service. Aegate welcomes this significant improvement and looks forward to working with all stakeholders to make it happen.'
Mark De Simone CEO, Aegate
The Aegate NMVO Stakeholder Guide – are you asking the right questions?
Our expert advice for stakeholders forming their local NMVO can be found here.
Ensure your country’s Authentication Service is the best in can be in terms of security, compliance, operation and governance.